Clinical Trials Browser

Phase 1/2 × peginterferon alfa-2b × Gynecologic × Clear all

NCT00085384 2012-08-02

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms